康辰药业股价微跌0.78% 新药临床试验完成首例入组

Group 1 - The stock price of Kangchen Pharmaceutical is reported at 53.57 yuan, down by 0.42 yuan or 0.78% from the previous trading day [1] - The stock reached a high of 55.09 yuan and a low of 53.34 yuan during the trading session, with a total transaction volume of 1.87 billion yuan [1] - Kangchen Pharmaceutical operates in the biopharmaceutical sector, focusing on the research and development of innovative drugs [1] Group 2 - The company has recently completed the enrollment of the first subject in the Phase I clinical trial for its self-developed drug KC1086, which is a small molecule inhibitor of lysine acetyltransferase 6, intended for the treatment of advanced solid tumors [1] - On August 21, the net inflow of main funds was 54.18 million yuan, while the net outflow over the past five days amounted to 1.48 billion yuan [1]